Status:
COMPLETED
Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)
Lead Sponsor:
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Conditions:
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 is an infection linked to a new coronavirus: SARS-CoV-2, which appeared in Wuhan in China at the end of 2019, and which has since spread around the world, responsible for a new major pandemic...
Detailed Description
Most of the descriptive studies relating to COVID-19 relate to the severe forms of the disease managed in the hospital sector. Few data have been published on moderate forms, requiring no hospitaliza...
Eligibility Criteria
Inclusion
- Age \>18 years
- COVID PCR + patient: Patient screened positive by PCR on nasopharyngeal swab
- or COVID-like patient: Patient not screened, but considered COVID + because contact with a COVID PCR + person, and presenting symptoms suggestive of COVID-19 among:
- Influenza-like illness (fever, body aches, arthralgia, etc.)
- Respiratory form: dyspnea, cough, rhinitis
- Gastrointestinal form: diarrhea, nausea, vomiting
- Anosmia and / or ageusia
- or patient COVID PCR-: If patient tested negative by PCR on nasopharyngeal swab, but showing signs suggestive of COVID-19.
Exclusion
- Patient objecting to the use of their data for research purposes
- Patient under justice or deprived of liberty.
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2020
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04402905
Start Date
June 15 2020
End Date
August 15 2020
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yasmine Dudoit
Paris, France, 75013